WO2006097205A3 - Verfahren zur extrakorporalen analyse von haarfollikelzellen - Google Patents
Verfahren zur extrakorporalen analyse von haarfollikelzellen Download PDFInfo
- Publication number
- WO2006097205A3 WO2006097205A3 PCT/EP2006/001946 EP2006001946W WO2006097205A3 WO 2006097205 A3 WO2006097205 A3 WO 2006097205A3 EP 2006001946 W EP2006001946 W EP 2006001946W WO 2006097205 A3 WO2006097205 A3 WO 2006097205A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair follicle
- hair
- homeostasis
- promoting
- maintaining
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Die vorliegende Erfindung betrifft ein Verfahren zur extrakorporalen Analyse von Haarfollikelzellen, ein Verfahren zur extrakorporalen Bestimmung der ATP- Syntheserate in Haarfollikelzellen, ferner ein Testverfahren zum Nachweis der Wirksamkeit von kosmetischen oder pharmazeutischen Wirkstoffen zur Aufrechterhaltung oder Förderung der Homeostase des Haarfollikels bzw. zur Behandlung pathologischer Zustände des Haarfollikels sowie ein Screening- Verfahren zur Identifikation von kosmetischen oder pharmazeutischen Wirkstoffen zur Aufrechterhaltung oder Förderung der Homeostase des Haarfollikels bzw. zur Behandlung pathologischer Zustände des Haarfollikels und ein Verfahren zur Herstellung einer kosmetischen oder pharmazeutischen Zubereitung zur Aufrechterhaltung oder Förderung der Homeostase des Haarfollikels bzw. zur Behandlung pathologischer Zustände des Haarfollikels. Weiterhin betrifft die Erfindung ein Haarbehandlungsmittel, enthaltend mindestens eine Verbindung, die ausgewählt ist unter L-Camitin oder L-Carnitinderivaten, sowie deren Verwendungen, insbesondere zur Aktivierung des Haarstoffwechsels.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06723191A EP1859272A2 (de) | 2005-03-14 | 2006-03-03 | Verfahren zur extrakorporalen analyse von haarfollikelzellen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200510011957 DE102005011957A1 (de) | 2005-03-14 | 2005-03-14 | Neues Haarbehandlungsmittel, enthaltend L-Carnitin oder L-Carnitinderivate |
DE102005011957.3 | 2005-03-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006097205A2 WO2006097205A2 (de) | 2006-09-21 |
WO2006097205A3 true WO2006097205A3 (de) | 2008-03-13 |
Family
ID=36992082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/001946 WO2006097205A2 (de) | 2005-03-14 | 2006-03-03 | Verfahren zur extrakorporalen analyse von haarfollikelzellen |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1859272A2 (de) |
DE (1) | DE102005011957A1 (de) |
WO (1) | WO2006097205A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005062356A1 (de) * | 2005-12-23 | 2007-06-28 | Henkel Kgaa | Verringerung der Haaralterung |
DE102006042243A1 (de) * | 2006-09-06 | 2008-03-27 | Henkel Kgaa | Mittel, enthaltend Biochinone und Betaine |
KR101483805B1 (ko) * | 2007-01-30 | 2015-01-16 | 파마시클릭스, 인코포레이티드 | 히스톤 데아세틸라제 억제제에 대한 암 내성을 확인하는 방법 |
FR2918267B1 (fr) * | 2007-07-03 | 2010-09-17 | Oreal | Utilisation de l-carnitine et/ou de ses derives pour attenuer, diminuer ou stopper la pousse des cheveux et des poils |
DE102009044974A1 (de) * | 2009-07-23 | 2011-01-27 | Henkel Ag & Co. Kgaa | Verwendung von Dihydroquercetin und mindestens einer Aminosäure zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses |
DE102009044975A1 (de) * | 2009-07-23 | 2011-01-27 | Henkel Ag & Co. Kgaa | Verwendung von Carnitin und Dihydroquercetin zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses |
DE102009044964A1 (de) * | 2009-09-24 | 2011-03-31 | Henkel Ag & Co. Kgaa | Verwendung einer Kombination aus Carnitin und/oder eines Carnitin-Derivats mit Purin und/oder einem Purin-Derivat zur Beeinflussung des natürlichen Pigmentierungsprozesses |
DE102009043486A1 (de) | 2009-09-30 | 2010-07-01 | Henkel Ag & Co. Kgaa | Verwendung von Wirkstoffen, erhältlich aus Pflanzen, zur Verhinderung und/oder Verminderung der Auswirkungen von psychoemotionalem Stress auf das Haar |
DE102009043485A1 (de) | 2009-09-30 | 2011-03-31 | Henkel Ag & Co. Kgaa | Verfahren zur Bestimmung von Stress |
US20110281256A1 (en) | 2010-05-17 | 2011-11-17 | Michael Glenn Davis | Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments |
DE102011079661A1 (de) * | 2011-07-22 | 2013-01-24 | Henkel Ag & Co. Kgaa | Verfahren zur individualisierten Haarbehandlung |
FR3090347B1 (fr) * | 2018-12-20 | 2020-12-18 | Oreal | Procédé de traitement des fibres kératiniques mettant en œuvre une composition comprenant un sel de carnitine ou de dérivé de carnitine comprenant un anion d’acide dicarboxylique aliphatique |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08127520A (ja) * | 1994-10-28 | 1996-05-21 | Kyotaro Hasunuma | 養毛化粧料 |
DE19539859A1 (de) * | 1995-10-26 | 1997-04-30 | Eugen Konrad | Haar und Hautbehandlungsmittel |
DE19618670A1 (de) * | 1996-05-09 | 1997-11-13 | Wella Ag | Haar- und Hautbehandlungsmittel |
DE19618671A1 (de) * | 1996-05-09 | 1997-11-13 | Wella Ag | Haar- und Hautbehandlungsmittel |
WO2002074265A1 (de) * | 2001-03-19 | 2002-09-26 | Hans Schwarzkopf Gmbh & Co. Kg | Haarbehandlungsmittel mit betainen |
WO2002094872A1 (en) * | 2001-05-24 | 2002-11-28 | Human Dna Technology Inc | Therapeutic uses of keratinocyte growth factor-2 |
WO2004028495A1 (de) * | 2002-09-19 | 2004-04-08 | Henkel Kommanditgesellschaft Auf Aktien | Haarbehandlungsmittel enthaltend eine wirkstoffkombination mit liposomen |
WO2004059002A2 (de) * | 2002-12-20 | 2004-07-15 | Henkel Kommanditgesellschaft Auf Aktien | Verfahren zur bestimmung der homeostase behaarter haut |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5741816A (en) * | 1994-06-20 | 1998-04-21 | Tanabe Seiyaku Co., Ltd. | Hair-growth agent |
US5885766A (en) * | 1995-02-17 | 1999-03-23 | Societe L'oreal S.A. | Method of screening of substances for their effect on the expression of mediators of inflammation in a hair follicle |
DE19631685A1 (de) * | 1996-08-06 | 1998-02-12 | Wella Ag | Hydrolytisch spaltbare Wirkstoffderivate, diese enthaltene Haarbehandlungsmittel und Verfahren zum Behandeln von Haaren |
WO1998034610A1 (en) * | 1997-02-10 | 1998-08-13 | Groton Robert B | Composition for improving hair regrowth and method of use |
DE10036797A1 (de) * | 2000-07-28 | 2002-02-07 | Beiersdorf Ag | Verwendung von Kombinationen mit einem Gehalt an Carnitinen |
DE10036798A1 (de) * | 2000-07-28 | 2002-02-07 | Beiersdorf Ag | Mittel zur Behandlung der Haare und der Kopfhaut |
CA2678135C (en) * | 2003-02-28 | 2012-12-04 | Elc Management Llc | Method for increasing hair growth using a creatine compound |
-
2005
- 2005-03-14 DE DE200510011957 patent/DE102005011957A1/de not_active Ceased
-
2006
- 2006-03-03 WO PCT/EP2006/001946 patent/WO2006097205A2/de not_active Application Discontinuation
- 2006-03-03 EP EP06723191A patent/EP1859272A2/de not_active Ceased
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08127520A (ja) * | 1994-10-28 | 1996-05-21 | Kyotaro Hasunuma | 養毛化粧料 |
DE19539859A1 (de) * | 1995-10-26 | 1997-04-30 | Eugen Konrad | Haar und Hautbehandlungsmittel |
DE19618670A1 (de) * | 1996-05-09 | 1997-11-13 | Wella Ag | Haar- und Hautbehandlungsmittel |
DE19618671A1 (de) * | 1996-05-09 | 1997-11-13 | Wella Ag | Haar- und Hautbehandlungsmittel |
WO2002074265A1 (de) * | 2001-03-19 | 2002-09-26 | Hans Schwarzkopf Gmbh & Co. Kg | Haarbehandlungsmittel mit betainen |
WO2002094872A1 (en) * | 2001-05-24 | 2002-11-28 | Human Dna Technology Inc | Therapeutic uses of keratinocyte growth factor-2 |
WO2004028495A1 (de) * | 2002-09-19 | 2004-04-08 | Henkel Kommanditgesellschaft Auf Aktien | Haarbehandlungsmittel enthaltend eine wirkstoffkombination mit liposomen |
WO2004059002A2 (de) * | 2002-12-20 | 2004-07-15 | Henkel Kommanditgesellschaft Auf Aktien | Verfahren zur bestimmung der homeostase behaarter haut |
Non-Patent Citations (5)
Title |
---|
GREEN M R ET AL: "RAPID ISOLATION IN LARGE NUMBERS OF INTACT VIABLE INDIVIDUAL HAIR FOLLICLES FROM SKIN BIOCHEMICAL AND ULTRASTRUCTURAL CHARACTERIZATION", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 87, no. 6, 1986, pages 768 - 770, XP002444989, ISSN: 0022-202X * |
PHILPOTT M P ET AL: "Human hair growth in vitro", JOURNAL OF CELL SCIENCE, CAMBRIDGE UNIVERSITY PRESS, LONDON, GB, vol. 97, no. 3, 1990, pages 463 - 471, XP003000714, ISSN: 0021-9533 * |
PHILPOTT M P ET AL: "METABOLIC STUDIES ON ISOLATED HAIR FOLLICLES: HAIR FOLLICLES ENGAGE IN AEROBIC GLYCOLYSIS AND DO NOT DEMONSTRATE THE GLUCOSE FATTY ACID CYCLE", JOURNAL OF INVESTIGATIVE DERMATOLOGY, NEW YORK, NY, US, vol. 96, no. 6, June 1991 (1991-06-01), pages 875 - 879, XP008063099, ISSN: 0022-202X * |
See also references of EP1859272A2 * |
WILLIAMS REBECCA ET AL: "Metabolism of freshly isolated human hair follicles capable of hair elongation: A glutaminolytic, aerobic glycolytic tissue", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 100, no. 6, 1993, pages 834 - 840, XP002444992, ISSN: 0022-202X * |
Also Published As
Publication number | Publication date |
---|---|
DE102005011957A1 (de) | 2006-12-07 |
WO2006097205A2 (de) | 2006-09-21 |
EP1859272A2 (de) | 2007-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006097205A3 (de) | Verfahren zur extrakorporalen analyse von haarfollikelzellen | |
Dobrota et al. | Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect | |
RU2008103480A (ru) | Средство, содержащее l-карнитин или производные l-карнитина и, по меньшей мере, одно определенное другое вещество | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
NO20081211L (no) | Xantinderivater som selektive HM74A agonister | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
NO20071549L (no) | Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler | |
WO2007127505A3 (en) | Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system | |
Zeng et al. | Mechanism of fisetin suppressing superoxide anion and xanthine oxidase activity | |
WO2009032773A3 (en) | Compositions and methods for treating demodex infestations | |
IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
EP3311818A3 (de) | Hemmer der bruton-tyrosinkinase zur behandlung solider tumore | |
EP1599213A4 (de) | Zellmembran-translokation von regulierten snare- inhibitoren, zusammensetzungen dafür und verfahren zur behandlung von erkrankungen | |
IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
WO2006119510A3 (en) | Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same | |
MY162640A (en) | Thioninium compounds and their use | |
WO2006096444A3 (en) | Chemical compounds | |
EA201001283A1 (ru) | Комбинация витамина d и 25-гидроксивитамина d3 | |
de Oliveira Azevedo et al. | Antinociceptive and anti-inflammatory effects of myricetin 3-O-β-galactoside isolated from Davilla elliptica: involvement of the nitrergic system | |
WO2002053774A3 (de) | Verfahren zur bestimmung der homeostase der haut | |
WO2017038951A1 (ja) | 黄ぐすみ低減用皮膚外用剤 | |
PL1868631T3 (pl) | Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej | |
WO2007077318A3 (fr) | Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau | |
HK1093016A1 (en) | Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition | |
WO2005052140A3 (en) | Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2006723191 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006723191 Country of ref document: EP |